Ogkologos

4396 ΔΗΜΟΣΙΕΥΣΕΙΣ 0 ΣΧΟΛΙΑ

Efficacy of Romiplostim In the Treatment and Prevention of Recurrence of...

Ogkologos - 26 Μαρτίου, 2026

FDA Approves Teclistamab in Combination with Daratumumab Hyaluronidase-fihj for Relapsed or...

Ogkologos - 25 Μαρτίου, 2026

First-Line Triplet Combination of Zolbetuximab, mFOLFOX6 and Nivolumab Supports Targeting CLDN18.2...

Ogkologos - 24 Μαρτίου, 2026

ESMO Calls for Cancer Care Integration in EU Global Health Resilience...

Ogkologos - 24 Μαρτίου, 2026

FX-909 Demonstrates Acceptable Safety and Preliminary Antitumour Activity, Establishing a Proof...

Ogkologos - 23 Μαρτίου, 2026

Pimicotinib Shows Robust Antitumour Activity and Clinically Meaningful Improvements in Patients...

Ogkologos - 18 Μαρτίου, 2026

FDA Grants Accelerated Approval to Zongertinib for Unresectable or Metastatic Non-Squamous...

Ogkologos - 18 Μαρτίου, 2026

Adding Gedatolisib to Fulvestrant, with or without Palbociclib, Improves PFS in...

Ogkologos - 17 Μαρτίου, 2026

Neoadjuvant GOLP Prolongs EFS Among Patients with Resectable High-Risk Intrahepatic Cholangiocarcinoma

Ogkologos - 16 Μαρτίου, 2026

New Survey Highlights the Role of Clinical Practice Guidelines to Improve...

Ogkologos - 12 Μαρτίου, 2026

1...222324...440 Σελίδα 23 από 440

MOST POPULAR

Combination of Enzalutamide Plus Abiraterone Acetate and Prednisone Offers No Clinical...

6 Απριλίου, 2023

Cancer in My Community: Working to Expand Access to Clinical Trials...

22 Σεπτεμβρίου, 2022

How My Cancer Diagnosis Has Fueled My Work in Improving Access...

19 Δεκεμβρίου, 2023

Capmatinib Shows Activity in Advanced NSCLC with a MET Exon 14...

8 Σεπτεμβρίου, 2020

Φόρτωση περισσοτέρων

Efficacy of Romiplostim In the Treatment and Prevention of Recurrence of...

FDA Approves Teclistamab in Combination with Daratumumab Hyaluronidase-fihj for Relapsed or...

First-Line Triplet Combination of Zolbetuximab, mFOLFOX6 and Nivolumab Supports Targeting CLDN18.2...

ESMO Calls for Cancer Care Integration in EU Global Health Resilience...

FX-909 Demonstrates Acceptable Safety and Preliminary Antitumour Activity, Establishing a Proof...

Pimicotinib Shows Robust Antitumour Activity and Clinically Meaningful Improvements in Patients...

FDA Grants Accelerated Approval to Zongertinib for Unresectable or Metastatic Non-Squamous...

Adding Gedatolisib to Fulvestrant, with or without Palbociclib, Improves PFS in...

Neoadjuvant GOLP Prolongs EFS Among Patients with Resectable High-Risk Intrahepatic Cholangiocarcinoma

New Survey Highlights the Role of Clinical Practice Guidelines to Improve...

MOST POPULAR

Combination of Enzalutamide Plus Abiraterone Acetate and Prednisone Offers No Clinical...

Cancer in My Community: Working to Expand Access to Clinical Trials...

How My Cancer Diagnosis Has Fueled My Work in Improving Access...

Capmatinib Shows Activity in Advanced NSCLC with a MET Exon 14...

HOT NEWS

FDA Approves Trifluridine and Tipiracil with Bevacizumab for Previously Treated Metastatic...

FDA Grants Accelerated Approval to Linvoseltamab-gcpt for Relapsed or Refractory Multiple...

Dual Inhibition of LAG-3 and PD-1 in Patients with Previously Untreated...

T-DM1 Approval Expanded to Include Some Women with Early-Stage HER2-Positive Breast...

ΔΗΜΟΦΙΛΕΊΣ ΘΈΣΕΙΣ

ΚΑΡΚΙΝΟΣ ΘΥΜΟΥ ΑΔΕΝΑ (ΘΥΜΩΜΑ)

ΣΤΑΤΙΣΤΙΚΑ

ΚΕΝΤΡΙΚΟΥ ΝΕΥΡΙΚΟΥ ΣΥΣΤΗΜΑΤΟΣ

ΔΗΜΟΦΙΛΗ ΚΑΤΗΓΟΡΙΑ